RARE PHOTOS: 2 | Rare Historical Photos

Is DaVita Stock Underperforming the S&P 500?

DaVita’s performance over the past year has fallen short of the broader S&P 500 Index, prompting a neutral outlook from analysts regarding its future prospects.

Barchart · Jun 24, 2025

DaVita Stock Outlook: Is Wall Street Bullish or Bearish?

DaVita has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Barchart · May 13, 2025

DaVita’s Q1 2025 Earnings: What to Expect

DaVita is expected to unveil its first-quarter results in the upcoming month, and analysts expect a significant double-digit drop in earnings.

Barchart · Apr 21, 2025

3 Warren Buffett Stocks That Are Smart Buys Now

Warren Buffett’s investment strategy has stood the test of time, delivering remarkable returns for decades. Currently, his portfolio includes Visa (V), VeriSign (VRSN), and DaVita (DVA) shares, which reflects his confidence in the long-term growth potential of these companies. So, could they be smart buys right now? Read on to…

StockNews.com · Feb 7, 2025

DaVita Earnings Preview: What to Expect

DaVita is set to announce its fourth-quarter results next month, with analysts forecasting a double-digit growth in the company’s bottom-line figure.

Barchart · Jan 17, 2025

DaVita Stock: Is DVA Outperforming the Healthcare Sector?

Despite DaVita’s recent outperformance relative to its broader sector, Wall Street analysts remain cautious about the stock’s prospects.

Barchart · Dec 24, 2024

Is Wall Street Bullish or Bearish on DaVita Stock?

While DaVita has outperformed the broader market over the past year, analysts on Wall Street are exercising caution regarding its future prospects.

Barchart · Nov 17, 2024

What to Expect From DaVita's Next Quarterly Earnings Report

DaVita is all set to release its third-quarter earnings this month, and analysts expect a single-digit profit dip.

Barchart · Oct 18, 2024

1 Outperforming Warren Buffett Stock That Still Looks Undervalued

This healthcare pick has outperformed the broader market in 2024, but is still priced at a discount.

Barchart · Sep 30, 2024

Is DaVita Stock Outperforming the Dow?

Although DaVita has outperformed the Dow Jones Industrials Average, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart · Sep 27, 2024